news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

another "sinopharm group" chairman and president resigned on the same day!

dandelion ouryao

source: company announcement compiled by: wangxinglai2004

on august 27, sinopharm modern pharmaceuticals issued an announcement stating that the company's chairman dong zenghe and president lian wanyong resigned on the same day.

on august 29, sinopharm group co., ltd. issued an announcement that due to work needs, mr. yu qingming will no longer serve as chairman of the board and mr. liu yong will no longer serve as president of the company. at the same time, mr. zhao bingxiang was elected as chairman of the company and mr. lian wanyong as president of the company, and their appointments will take effect immediately.

recently, sinopharm group co., ltd. issued an announcement. due to work needs:

mr. yu qingming will no longer serve as chairman of the board, executive director, chairman of the nomination committee, chairman of the strategy and investment committee and member of the legal compliance and environmental, social and governance committee of the board;

mr. liu yong will no longer serve as executive director, president, member of the strategy and investment committee and member of the legal compliance and environmental, social and governance committee. mr. yu and mr. liu will be appointed to other positions by sinopharm group co., ltd.

pursuant to the resolution of the company's board of directors on august 27, 2024, it is recommended to appoint mr. zhao bingxiang as a non-executive director, and to appoint mr. lian wanyong as an executive director. at the same time, mr. zhao bingxiang was elected as the chairman of the company's board of directors, and his appointment will take effect after approval by the company's special general meeting of shareholders; mr. lian wanyong was appointed as the president of the company, and his appointment will take effect immediately.

among them, mr. lian wanyong:

from december 2008 to january 2018, he served as a director and supervisor of the company;

from january 2018 to september 2022, he served as vice president and party committee member of the company. during this period, he also served as a director of china national accord medicines co., ltd. and china national medicines group co., ltd.;

from september 2022 to august 2024, he served as director, president, and deputy secretary of the party committee of shanghai shyndec pharmaceutical co., ltd.;

on august 27, 2024, sinopharm modern pharmaceuticals issued an announcement stating that due to work arrangement adjustments, lian wanyong applied to resign from the positions of director and president, and will no longer hold any position in the company after his resignation.

about the company:

according to the china national pharmaceutical group corporation atlas, sinopharm holdings co., ltd. is a second-level subsidiary of china national pharmaceutical group corporation. the listed companies under china national pharmaceutical group corporation include sinopharm holdings co., ltd., sinopharm group pharmaceutical co., ltd., shanghai modern pharmaceutical co., ltd., beijing tiantan biological products co., ltd., etc.;

china national pharmaceutical group corporation has recently seen frequent personnel changes:

in march 2024, sinopharm holdings issued an announcement that li hao applied to resign from the position of chief financial officer and wei dongsong applied to resign from the position of secretary of the board of directors. at the same time, zu jing was appointed as the company's chief financial officer and zhang zhongxi was appointed as the company's vice president and secretary of the board of directors.

in june 2024, bai zhongquan was appointed as party secretary and chairman of china national pharmaceutical group corporation.

in july 2024, sinopharm holdings issued an announcement that li hao applied to resign from his position as the company's vice president and other related positions; also in july, the company's vice president gong zhong applied to resign due to retirement age.

in august 2024, sinopharm modern pharmaceuticals announced that its chairman dong zenghe and president lian wanyong resigned on the same day. dong zenghe had just taken over the leadership in june last year.

worth noting:

in january 2024, according to the website of the central commission for discipline inspection and the national supervisory commission, zhou bin, former member of the party committee and deputy general manager of china national pharmaceutical group co., ltd. and former party secretary and chairman of shanghai shyndec pharmaceutical, was investigated for suspected serious violations of discipline and law. at this time, he had only been out of office for about 6 months.

in april 2024, yang xiaoming, formerly the chief engineer and chief scientist of china national pharmaceutical group co., ltd. and chief scientist of china biotechnology co., ltd., and once known as the "father of china's covid-19 vaccine", was investigated for suspected serious violations of discipline and law;